{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:44:01Z","timestamp":1790030641198,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["1473233"],"award-info":[{"award-number":["1473233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Foundation from the Sci-Tech Office of Guangdong Province","award":["2016A020215083"],"award-info":[{"award-number":["2016A020215083"]}]},{"name":"Science Foundation from the Sci-Tech Office of Foshan City","award":["2015AB00294"],"award-info":[{"award-number":["2015AB00294"]}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.radonc.2018.10.010","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T13:15:43Z","timestamp":1540300543000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"132","author":[{"given":"Shao-Bo","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.10.010_b0005","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","article-title":"Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up","volume":"51","author":"Zhang","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2018.10.010_b0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.oraloncology.2015.08.005","article-title":"Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis","volume":"51","author":"Zhang","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0015","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00432-017-2401-y","article-title":"A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma","volume":"143","author":"Qiu","year":"2017","journal-title":"Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00066-016-0959-y","article-title":"IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma: survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)","volume":"192","author":"Moon","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2018.10.010_b0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer\u2014success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0030","doi-asserted-by":"crossref","first-page":"38381","DOI":"10.18632\/oncotarget.5420","article-title":"Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost","volume":"6","author":"Ou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2018.10.010_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oraloncology.2015.11.015","article-title":"Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma","volume":"53","author":"Setton","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.radonc.2014.01.011","article-title":"Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin","volume":"110","author":"Lin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-9-56","article-title":"Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma","volume":"9","author":"Yi","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0055","doi-asserted-by":"crossref","first-page":"43450","DOI":"10.18632\/oncotarget.15896","article-title":"The challenge in treating locally recurrent T3\u20134 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2018.10.010_b0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijrobp.2017.11.038","article-title":"Prospective, multicenter, phase 2 trial of induction chemotherapy followed by bio-chemoradiotherapy for locally advanced recurrent nasopharyngeal carcinoma","volume":"100","author":"Ng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.010_b0065","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","article-title":"Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial","volume":"388","author":"Zhang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2018.10.010_b0070","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2001.19.10.2607","article-title":"Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival","volume":"19","author":"Lin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2407-14-136","article-title":"Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2018.10.010_b0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2015.08.003","article-title":"The prognostic value of plasma Epstein-Barr Viral DNA and tumor response to neoadjuvant chemotherapy in advanced-stage nasopharyngeal carcinoma","volume":"93","author":"Liu","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.010_b0085","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.10.010_b0090","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.25011\/cim.v40i1.28049","article-title":"Prognostic role of plasma Epstein-Barr virus DNA load for nasopharyngeal carcinoma: a meta-analysis","volume":"40","author":"Liu","year":"2017","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.radonc.2018.10.010_b0095","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.radonc.2018.10.010_b0100","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0110","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.7150\/jca.20351","article-title":"Survival and toxicities of IMRT based on the RTOG protocols in patients with nasopharyngeal carcinoma from the endemic regions of China","volume":"8","author":"Liang","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2018.10.010_b0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiology.177.2.2217772","article-title":"Cervical lymph node metastasis: assessment of radiologic criteria","volume":"177","author":"Van den Brekel","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2018.10.010_b0120","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1158\/1078-0432.CCR-08-0271","article-title":"The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging","volume":"14","author":"Mao","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2018.10.010_b0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7150\/jca.17957","article-title":"Magnetic resonance imaging-detected tumor residue after intensity-modulated radiation therapy and its association with post-radiation plasma epstein-barr virus deoxyribonucleic acid in nasopharyngeal carcinoma","volume":"8","author":"Lv","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2018.10.010_b0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2018.10.010_b0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000360178","article-title":"Pretreatment Epstein-Barr virus DNA load and cumulative cisplatin dose intensity affect long-term outcome of nasopharyngeal carcinoma treated with concurrent chemotherapy: experience of an institute in an endemic area","volume":"37","author":"Wei","year":"2014","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.radonc.2018.10.010_b0140","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.10.010_b0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7150\/jca.16732","article-title":"Induction chemotherapy improved long-term outcomes of patients with locoregionally advanced nasopharyngeal carcinoma: a propensity matched analysis of 5-year survival outcomes in the era of intensity-modulated radiotherapy","volume":"8","author":"Peng","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2018.10.010_b0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0360-3016(95)00157-T","article-title":"Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study","volume":"33","author":"Jaulerry","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.010_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hed.2880120106","article-title":"Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx","volume":"12","author":"Bataini","year":"1990","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2018.10.010_b0160","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hed.20093","article-title":"Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma","volume":"26","author":"Yau","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2018.10.010_b0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijrobp.2007.10.027","article-title":"Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma","volume":"71","author":"Hara","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.010_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090048","article-title":"Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma","volume":"9","author":"Wan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2018.10.010_b0175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ijrobp.2009.08.072","article-title":"External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up","volume":"78","author":"Schinagl","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.010_b0180","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/cam4.1381","article-title":"Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognosticvalue in nasopharyngeal carcinoma: a retrospective study","volume":"7","author":"He","year":"2018","journal-title":"Cancer Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T21:34:48Z","timestamp":1605303288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018335229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"alternative-id":["S0167814018335229"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.010","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}